Dr Andreas Schneider
Innovation & Business Development Manager

Is this your profile?

About

Andreas Schneider is Innovation & Business Development Manager with Ypsomed Delivery Systems. His responsibilities include the definition and development of new platform devices with a particular emphasis on connected and smart device systems. As such, he has been actively involved in the design and development of SmartPilot for YpsoMate, a reusable connected add-on that transforms the proven two-step autoinjector into a connected system. Dr Schneider has published various articles and held presentations in the areas of innovation management and drug delivery. He received his PhD in Innovation Management and Organisation Sciences from ETH Zurich, Switzerland.

Contributions

HOW USERS DISTINGUISH BETWEEN SELF-INJECTION DEVICE PLATFORM VARIANTS

Andreas Schneider highlights how the ever-increasing interest in device platforms raises concerns around the broad availability of lookalike autoinjectors that may result in inappropriate medication usage. He summarises a recent empirical study¹ providing insights into which device attributes drive device distinguishability.

More contributions

I SPY WITH MY LITTLE EYE: EYE TRACKING DRIVES PATIENT-CENTRED DEVELOPMENT OF CONNECTED SYSTEMS

The development of connected self-injection systems is driving industry to rethink its current approaches to patient-centred new product development. Andreas Schneider summarises a recent field study that used eye tracking for the formative usability testing of SmartPilot for YpsoMate.

PREFILLED SYRINGES

SIMPLE AND SECURE ADHERENCE MONITORING: YDS SMARTSERVICES™ FOR END-TO-END SMART DEVICE INTEGRATION

Whilst there is much discussion on how to apply connectivity and smart devices to therapies, there is far less dialogue concerning the challenges inherent to the digital architecture needed to make such innovations work in practice. Andreas Schneider introduces YDS SmartServices™, Ypsomed’s digital turnkey solution to effectively embed smart devices in a broader digital ecosystem.

PREFILLED SYRINGES

A NEW VALUE PROPOSITION OF SMART DEVICES: ADVANCED MEDICATION ADHERENCE MONITORING IN CLINICAL TRIALS

Andreas Schneider explores a new value proposition of smart injection systems, introducing how advanced adherence monitoring services resolve some of the key challenges of clinical research practice regarding costs, adherence, data quality and integrity, Dr Schneider explains which technical features are needed for smart devices to provide value-adding adherence monitoring services, using SmartPilot for YpsoMate as a case study.

PREFILLED SYRINGES

INSIGHTS FROM THE YPSOMATE SMART CASE STUDY

Andreas Schneider provides insights into recent development activities at Ypsomed in the area of smart self-injection systems.

PREFILLED SYRINGES

FAST & LOW-RISK CUSTOMISATION OF INNOVATIVE INJECTION SYSTEMS

Andreas Schneider highlights new emerging requirements of biopharma companies and describes how Ypsomed has established a range of innovative platform products, based on proven expertise and capabilities, and well-honed development and manufacturing processes, in order to meet its biopharma partners’ and customers’ needs fully and completely.

Top

W3 Total Cache is currently running in Pro version Development mode.